Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes

被引:21
作者
Ayyavoo, V [1 ]
Kudchodkar, S [1 ]
Ramanathan, MP [1 ]
Le, P [1 ]
Muthumani, K [1 ]
Megalai, NM [1 ]
Dentchev, T [1 ]
Santiago-Barrios, L [1 ]
Mrinalini, C [1 ]
Weiner, DB [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Stellar Chance Labs, Philadelphia, PA 19104 USA
关键词
HIV-1; fusion protein; immunogen; vaccine; gene construct; immune response; T helper cell; cell-mediated response;
D O I
10.1097/00002030-200001070-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To develop an HIV-1 accessory gene:immunogen using a DNA vaccine approach. Methods: HIV-1 accessory genes vit: vpu and nef were modified to express under the control of a single promoter with cellular proteolytic cleavage sites between the coding sequences (VVN-P). Immune responses induced by these constructs were evaluated in mice. Results: DNA vaccine construct (pVVN-P) expressing Vif, Vpu and Nef was processed and the fusion protein was cleaved appropriately. Vif, Vpu and Nei as a fusion protein with proteolytic cleavage sites (VVN-P) is able to induce a significant level of cellular immune responses. We also observed that accessory genes Vii, Vpu and Nef (VVN-P) induced an effective T helper 1 proliferative response measured by cytokine production. Furthermore, expression cassette pVVN-P was able to induce cytotoxic T lymphocyte (CTL) responses against diverse HIV-1 viruses in infected target cells. Conclusion: We conclude that cell-mediated immune responses induced by accessory gene constructs from clade B may have a broader recognition of divergent HIV-l viruses and should be further examined for both prophylactic and therapeutic vaccination schemes against HIV-1. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 34 条
[1]   CYTOKINES - COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES [J].
ARAI, K ;
LEE, F ;
MIYAJIMA, A ;
MIYATAKE, S ;
ARAI, N ;
YOKOTA, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 :783-836
[2]   Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes [J].
Ayyavoo, V ;
Nagashunmugam, T ;
Boyer, J ;
Mahalingam, S ;
Fernandes, LS ;
Le, P ;
Lin, J ;
Nguyen, C ;
Chattargoon, M ;
Goedert, JJ ;
Friedman, H ;
Weiner, DB .
AIDS, 1997, 11 (12) :1433-1444
[3]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[4]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[5]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[6]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[7]   CYTOTOXIC LYMPHOCYTE-T RESPONSES IN THE PERIPHERAL-BLOOD OF CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED MOTHERS [J].
CHEYNIER, R ;
LANGLADEDEMOYEN, P ;
MARESCOT, MR ;
BLANCHE, S ;
BLONDIN, G ;
WAINHOBSON, S ;
GRISCELLI, C ;
VILMER, E ;
PLATA, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) :2211-2217
[8]   HIV-1 auxiliary proteins: Making connections in a dying cell [J].
Cullen, BR .
CELL, 1998, 93 (05) :685-692
[9]   Expression cloning of new receptors used by simian and human immunodeficiency viruses [J].
Deng, HK ;
Unutmaz, D ;
KewalRamani, VN ;
Littman, DR .
NATURE, 1997, 388 (6639) :296-300
[10]   Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients [J].
Durali, D ;
Morvan, J ;
Letourneur, F ;
Schmitt, D ;
Guegan, N ;
Dalod, M ;
Saragosti, S ;
Sicard, D ;
Levy, JP ;
Gomard, E .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3547-3553